genfibrozilo 600 mg
halewood laboratories pvt. ltd. - genfibrozilo - tableta revestida - 600 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - agentes antineoplásicos - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
enzalutamida 40 mg
lotus pharmaceuticals co. ltd - enzalutamida - cápsula blanda - 40 mg
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - bloqueo neuromuscular - todos los demás productos terapéuticos - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
lacosamide adroiq
extrovis eu ltd. - lacosamida - epilepsia - los antiepilépticos, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
firazyr
shire human genetic therapies s.a. - icatibant - solucion inyectable - icatibant 30 mg
icatibant 30 mg/3ml solución inyectable 30 mg/ mg/3 ml
asta médica centroamericana - solución inyectable - 30 mg/ mg/3 ml
picato gel tópico 0,015% (mebutato de ingenol)
deutsche pharma s.a. - sin formulas
picato gel tópico 0,05% (mebutato de ingenol)
deutsche pharma s.a. - sin formulas
iscaten 200 mg ampollas
laboratorios klinos, c.a. - cimetidina - solucion intravenosa - 200 mg/2 ml